IHR Participates in Nation-wide Study on Pregnancy and COVID-19
In order to help promote the care and safety of our pregnant patients and their babies during the COVID-19 pandemic, IHR has partnered up with other clinics across the U.S. in the ASPIRE Study. So far 79 clinics/networks strong across 27 states, and 275 patients have already enrolled.
Are you interested in signing up?
All pregnant patients are eligible to participate. We encourage you to consider it and are here to answer any questions you may have. During this unprecedented time, we know there can be more questions than answers. This study is an important step in providing better fertility care under new global conditions.
To participate or learn more, please visit aspire.ucsf.edu
Alternatively, please email aspire@ucsf.edu with your contact information. A study coordinator will be in touch regarding enrolling in the ASPIRE study.
Aspire in the News
Watch an interview with ASPIRE investigator Dr. Huddleston and an impressive participant about the study (on ABC).
Questions?
Check out ASPIRE’s FAQ page for prospective patients - https://aspire.ucsf.edu/interested-participants
Learn how to maximize your chances of conception
By submitting this form, you agree to receive personalized email communications from Pinnacle at the email you provided. You may unsubscribe at any time. View our Privacy Policy
Related Blogs
Infertility Resources & Support
Structural Abnormalities and Infertility
Several developmental abnormalities of the uterus can be discovered during an infertility evaluation. A unicornuate uterus, septum or septate uterus, and a bicornuate uterus are among the numerous structural anomalies. These problems arise when the uterus is being formed. A unicornuate uterus is when only one side of the uterus is formed normally.
In the Media
Dr. Tur-Kaspa featured in National Geographic special issue on the Future of Medicine
National Geographic’s January 2019 features IHR’s approach of personalized medicine and how IHR uses the Endometrial Receptivity Analysis (ERA) for increasing conception rates by personalized Embryo Transfer (pET).
